Century Therapeutics (IPSC) Other Gross PP&E Adjustments (2022 - 2025)
Century Therapeutics (IPSC) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $80.9 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 20.96% to $80.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.9 million through Dec 2025, up 20.96% year-over-year, with the annual reading at $80.9 million for FY2025, 20.96% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was $80.9 million at Century Therapeutics, down from $81.6 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $81.6 million in Q3 2025, with the low at $53.4 million in Q2 2022.
- Average Other Gross PP&E Adjustments over 4 years is $69.8 million, with a median of $68.9 million recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments soared 47.18% in 2023, then fell 13.27% in 2024.
- Over 4 years, Other Gross PP&E Adjustments stood at $65.9 million in 2022, then increased by 10.12% to $72.5 million in 2023, then decreased by 7.79% to $66.9 million in 2024, then rose by 20.96% to $80.9 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $80.9 million, $81.6 million, and $69.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.